KR102061317B1 - Kits for detecting hair loss disorders with Single Nucleotide Polymorphism and method for detecting hair loss disorders thereby - Google Patents
Kits for detecting hair loss disorders with Single Nucleotide Polymorphism and method for detecting hair loss disorders thereby Download PDFInfo
- Publication number
- KR102061317B1 KR102061317B1 KR1020180145519A KR20180145519A KR102061317B1 KR 102061317 B1 KR102061317 B1 KR 102061317B1 KR 1020180145519 A KR1020180145519 A KR 1020180145519A KR 20180145519 A KR20180145519 A KR 20180145519A KR 102061317 B1 KR102061317 B1 KR 102061317B1
- Authority
- KR
- South Korea
- Prior art keywords
- hair loss
- primer
- dna
- amplification
- predicting
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Abstract
Description
본 발명은 탈모 예측용 키트에 관한 것으로, 더욱 상세하게는, 탈모에 영향을 미치는 12개의 단일염기다형성(SNP)을 선발하여 제작한 탈모 예측용 키트 및 이를 이용한 탈모 예측방법에 관한 것이다.The present invention relates to a kit for predicting hair loss, and more particularly, to a kit for predicting hair loss produced by selecting 12 single base polymorphisms (SNPs) that affect hair loss and a method for predicting hair loss using the same.
최근 신체적, 정신적 스트레스 및 유전적 원인 등으로 탈모환자가 급증하여 발모제 및 탈모 치료관련 산업이 급성장하고 있어, 탈모현상에 관한 정확한 원인 규명과 치료예방의 필요성이 증가하고 있다. 탈모는 진행성 질환으로, 유전적 소인을 가진 사람의 탈모는 아주 천천히 진행되며, 탈모의 진행 속도와 진행 정도는 개인차가 있으나, 대부분의 탈모 환자는 초기에 적절한 약물치료로 탈모의 진행을 멈출 수 있어, 조기 진단을 통한 치료가 매우 중요하다. Recently, hair loss patients and the hair loss treatment industry is growing rapidly due to physical and mental stress and genetic causes, and the need for accurate identification of the hair loss phenomenon and prevention of treatment is increasing. Hair loss is a progressive disease, and hair loss in people with genetic predisposition is very slow, and the progress and progression of hair loss vary greatly.However, most hair loss patients can stop the progression of hair loss with proper drug treatment at an early stage. Therefore, treatment through early diagnosis is very important.
그러나 아직까지 탈모 환자의 진단은 대부분 전통적인 진단방법인 자가진단, 털이 빠진 부위에 대한 사진, 미네랄 검사 등의 임상방법으로 이루어지고 있다. 그 중, 현미경을 이용한 사진검사 및 자가진단은 주관적 요소가 내포되어 있고, 고비용의 모발 미네랄 검사는 탈모와는 무관한 검사를 시행하고 있어, 정확한 탈모의 예측이 불가한 문제가 있다.However, most of the hair loss patients have been diagnosed by traditional methods such as self-diagnosis, photos of missing hairs, and mineral test. Among them, the microscopic photographic examination and self-diagnosis include subjective factors, and the expensive hair mineral examination is conducted irrelevant to hair loss, so that accurate hair loss prediction is impossible.
한편, 국내의 질병관련 SNP(single nucleotide polymorphism) 발굴 기술은 기술적으로 가장 앞선 미국의 20% 수준으로 평가되고 있으며(생명공학연구원 BioZine), 유전자 진단 분석에 필수적인 SNP 마커 개발은 아직 초보 단계로 우수한 기술의 확보가 필요하다. 국내의 크로마흐사는 남성형 탈모 메커니즘에서 잘 알려진 남성 호르몬 5α-리덕테이즈(reductase)의 정량검출을 통해 탈모 가능성을 확인하고 있으나, 탈모관련 연구보고에 의하면 5α-리덕테이즈에 따른 정상인과 탈모환자 사이에 특이적 차이가 없다는 연구결과가 보고되어(S. Redler et al. 2012), 탈모를 정확하게 예측 진단할 방안이 되지 않는다. 따라서, 탈모를 정확하게 예측하여 치료에 활용 가능한 방안의 개발이 절실히 필요한 실정이다.On the other hand, domestic disease-related single nucleotide polymorphism (SNP) discovery technology is ranked as the most technologically advanced 20% in the US (Biotechnology, Biotechnology Research Institute), and the development of SNP markers essential for genetic diagnostic analysis is still at an early stage. It is necessary to secure. In Korea, Chromach has confirmed the possibility of hair loss through the quantitative detection of the male hormone 5α-reductase, which is well known in the male-type hair loss mechanism. There has been a report of no specific differences between the two (S. Redler et al. 2012), which is not an accurate predictive diagnosis of hair loss. Therefore, there is an urgent need to develop a method that can be used for treatment by accurately predicting hair loss.
탈모환자와 관련하여 대부분의 연구에서는 안드로겐 수용체(androgen receptor)의 유전자 다형성(gene polymorphism)을 검사하기 위해, 주로 PCR-RFLP(polymerase chain reaction-restriction enzyme length polymorphism)법이 활용되어 왔으나, 이 방법은 제한효소를 사용하기 때문에 복잡하고, 분석시간이 오래 걸리며 정확성이 떨어지는 단점이 있어왔다. 게다가, 탈모는 유전적 요인이 강한 질환으로 알려졌기 때문에 본 발명에서는 정확한 예측 및 조기관리가 가능한 탈모 예측용 키트(Kit)를 개발하여 제공하고자 한다. Most studies on alopecia patients have mainly used polymerase chain reaction-restriction enzyme length polymorphism (PCR-RFLP) to test the gene polymorphism of the androgen receptor. The use of restriction enzymes has the disadvantages of complexity, long analysis time and poor accuracy. In addition, since hair loss is known to be a disease with a strong genetic factor, the present invention intends to develop and provide a kit for predicting hair loss (Kit) capable of accurate prediction and early management.
본 발명은 서열번호 1 내지 24의 핵산서열로 표시되는 각각의 프라이머들을 포함하는 것을 특징으로 하는 탈모 예측 SNP 마커 검출용 프라이머 세트를 제공한다. 이때, 상기 탈모 예측 SNP 마커 검출용 프라이머 세트는, 바람직하게 서열번호 25 내지 36의 핵산서열로 표시되는 각각의 프라이머들을 더 포함하는 것이 좋다. The present invention provides a primer set for detecting hair loss predicting SNP markers, comprising primers represented by nucleic acid sequences of SEQ ID NOs: 1 to 24. In this case, the primer set for detecting the hair loss predicting SNP marker may preferably further include respective primers represented by nucleic acid sequences of SEQ ID NOs: 25 to 36.
한편, 본 발명은 서열번호 1 내지 24의 핵산서열로 표시되는 각각의 프라이머들 및 서열번호 25 내지 36의 핵산서열로 표시되는 각각의 프라이머들을 포함하는 SNP 마커 검출용 프라이머 세트를 포함하는 것을 특징으로 하는 탈모 예측용 진단키트를 제공한다. On the other hand, the present invention is characterized in that it comprises a primer set for detecting the SNP markers comprising each primer represented by the nucleic acid sequence of SEQ ID NO: 1 to 24 and each primer represented by the nucleic acid sequence of SEQ ID NO: 25 to 36 It provides a diagnostic kit for predicting hair loss.
한편, 본 발명은 인간 DNA의 rs6113491, rs201571, rs1998076, rs6137444, rs2180439, rs1352015, rs1160312, rs756853, rs2249817, rs7910290, rs6601957 및 rs11253156를 포함하도록 PCR 증폭하여 증폭산물을 회수하는 단계 (a); 및, 상기 증폭산물에서, rs6113491, rs201571, rs1998076, rs6137444, rs2180439, rs1352015, rs1160312, rs756853, rs2249817, rs7910290, rs6601957 및 rs11253156의 단일염기다형성을 분석하여 개별 유전자형을 결정하는 단계 (b);를 포함하는 것을 특징으로 하는 탈모 예측 방법을 제공한다. Meanwhile, the present invention provides a method for recovering amplification products by PCR amplifying rs6113491, rs201571, rs1998076, rs6137444, rs2180439, rs1352015, rs1160312, rs756853, rs2249817, rs7910290, rs6601957 and rs11253156 of human DNA (a); And determining the individual genotypes by analyzing single base polymorphisms of rs6113491, rs201571, rs1998076, rs6137444, rs2180439, rs1352015, rs1160312, rs756853, rs2249817, rs7910290, rs6601957 and rs11253156 in the amplification product (b); A hair loss prediction method is provided.
본 발명의 탈모 예측방법은, 상기 단계 (b) 후, 바람직하게 개별 유전자형에 따른 탈모 형질을 분석하고, 탈모 예상 정도를 판정하는 단계 (c);를 더 포함하는 것이 좋다. Hair loss prediction method of the present invention, after the step (b), preferably analyzing the hair loss traits according to the individual genotype, and determining the degree of hair loss expected (c); may further comprise a.
본 발명의 키트를 이용하면 탈모환자의 조기 예측 및 조기관리가 가능하여 알맞은 탈모관리가 용이하고, 그에 부가하여 개선 제품을 제안하는 서비스도 가능할 것이어서 시장성이 확대되는 효과가 있다.By using the kit of the present invention, early prediction and early management of alopecia patients can be facilitated, and a proper hair loss management can be performed.
또한, 탈모의 조기 예측에 의한 치료 효과의 극대화, 그에 따른 치료 비용 및 분석 비용의 절감으로 인한 경제적 효과도 기대할 수 있다.In addition, the economic effect of maximizing the treatment effect by the early prediction of hair loss, the resulting treatment cost and analysis cost reduction can be expected.
도 1은 NGS 타켓 농축법의 모식도를 나타낸 것이다.
도 2는 염기서열 생성 모식도를 나타낸 것이다.
도 3은 유전자형 판독의 정확성을 확인하기 위한 방법(SNaPshot assay)의 모식도이다.
도 4는 SNPs에 대한 12개의 SBE 프라이머를 조합하여 동시에 증폭될 수 있도록 멀티플렉스 SNP 익스텐션 어세이(multiplex SNP extension assay)를 수행하여 유전분석을 통해 탈모예측을 검증한 결과이다.Figure 1 shows a schematic diagram of the NGS target concentration method.
Figure 2 shows a base sequence generation schematic.
3 is a schematic diagram of a method (SNaPshot assay) for confirming the accuracy of genotyping.
Figure 4 is a result of verifying the hair loss prediction through genetic analysis by performing a multiplex SNP extension assay (multiplex SNP extension assay) to be amplified at the same time by combining the 12 SBE primers for the SNPs.
현재 미국 내 23andMe, TheMakingsofMe사를 포함하여 10여 개 이상의 회사에서 유전자검사가 성업 중이며, 특히 TheMakingsofMe사는 탈모와 연관된 SNP 마커를 이용한 DNA 검사 서비스를 제공하고 있지만, 4개의 유전적 마커만을 검사하기 때문에 탈모 예측 정확도가 낮다. 국내에서도 탈모 관련 DTC(Direct-To-Consumer) 검사의 규제가 풀리면서 국내 업체들이 앞다투어 검사 서비스를 진행하고 있지만, 이 역시도 4개의 탈모 관련 SNP만이 허가되어 탈모 예측 정확도가 낮은 문제가 있다.More than 10 companies are currently doing genetic testing, including 23andMe and TheMakingsofMe in the United States. In particular, TheMakingsofMe offers DNA testing services using SNP markers related to hair loss, but only because it tests only four genetic markers. The prediction accuracy is low. In Korea, as the regulation of hair loss-related DTC (Direct-To-Consumer) test is lifted, domestic companies are in the process of testing. However, only four hair loss-related SNPs are allowed, which leads to low accuracy of hair loss prediction.
따라서, 본 발명에서는 NGS 기법을 이용하여 정확도 높은 12개의 탈모 예측 SNP 마커를 발굴하고, 이를 이용하여 맞춤형 탈모 예측진단 키트를 개발함으로써, 탈모 관련 SNP의 다형성(polymorphism)을 검사하고, 탈모 진행 여부 등을 예측하여 맞춤형 탈모 치료가 가능한 과학적인 유전자 관리 시스템을 구축하고자 하였다. Therefore, the present invention finds 12 highly accurate hair loss predictive SNP markers using the NGS technique, and develops a customized hair loss predictive diagnosis kit by using the same. We anticipated to establish a scientific gene management system that can be customized for hair loss treatment.
이를 위하여, 본 발명은 서열번호 1 내지 24의 핵산서열로 표시되는 각각의 프라이머들을 포함하는 것을 특징으로 하는 탈모 예측 SNP 마커 검출용 프라이머 세트를 제공한다. 이때, 상기 탈모 예측 SNP 마커 검출용 프라이머 세트는, 바람직하게 서열번호 25 내지 36의 핵산서열로 표시되는 각각의 프라이머들을 더 포함하는 것이 좋다. 본 발명에서 서열번호 1 내지 24의 핵산서열로 표시되는 각각의 프라이머들은 본 발명에서 목표로 하는 탈모 예측 SNP 마커 '증폭용' 프라이머 세트이고, 서열번호 25 내지 36의 핵산서열로 표시되는 각각의 프라이머들은, 상기 서열번호 1 내지 24의 핵산서열로 표시되는 각각의 프라이머들을 포함하는 탈모 예측 SNP 마커 증폭용 프라이머 세트를 사용하여 증폭한 증폭산물 (SNP 함유 핵산서열들)을 염료(dye)에 의해 시각적으로 확인할 수 있게 하는 '확인용' SBE(single-base extension) 프라이머 세트이다.To this end, the present invention provides a primer set for detecting hair loss predicting SNP markers, comprising primers represented by nucleic acid sequences of SEQ ID NOs: 1 to 24. In this case, the primer set for detecting the hair loss predicting SNP marker may preferably further include respective primers represented by nucleic acid sequences of SEQ ID NOs: 25 to 36. In the present invention, each of the primers represented by the nucleic acid sequences of SEQ ID NOs: 1 to 24 is a hair loss predicting SNP marker 'amplification' primer set targeted in the present invention, and each primer represented by the nucleic acid sequences of SEQ ID NOs: 25 to 36. The amplification products (SNP-containing nucleic acid sequences) amplified using a primer set for amplifying hair loss predicting SNP markers including the respective primers represented by the nucleic acid sequences of SEQ ID NOs: 1 to 24 were visually identified by dye. This is a set of 'check' single-base extension (SBE) primers.
또한, 본 발명은 서열번호 1 내지 24의 핵산서열로 표시되는 각각의 프라이머들 및 서열번호 25 내지 36의 핵산서열로 표시되는 각각의 프라이머들을 포함하는 SNP 마커 검출용 프라이머 세트를 포함하는 것을 특징으로 하는 탈모 예측용 진단키트를 제공하는데, 본 발명의 탈모 예측용 진단키트는 바람직하게 PCR (polymerase chain reaction) 키트인 것이 좋다. 본 발명의 탈모 예측용 진단키트는 프라이머 세트 외에 버퍼 등을 포함하여 구성된다. PCR 진단키트에서 프라이머 외에 부수적으로 사용되는 성분들은 널리 알려져 있기 때문에 이에 대한 구체적인 기재는 생략하기로 한다. In addition, the present invention is characterized in that it comprises a primer set for detecting the SNP markers comprising each primer represented by the nucleic acid sequence of SEQ ID NO: 1 to 24 and each primer represented by the nucleic acid sequence of SEQ ID NO: 25 to 36 To provide a diagnostic kit for predicting hair loss, the diagnostic kit for predicting hair loss of the present invention is preferably a polymerase chain reaction (PCR) kit. The diagnostic kit for predicting hair loss of the present invention includes a buffer and the like in addition to the primer set. In addition to the primers used in the PCR diagnostic kit as a secondary component is widely known, so a detailed description thereof will be omitted.
본 발명에서는 탈모군과 대조군의 SNP를 비교하여 탈모군에서 특징적으로 발견되는 12개의 SNP를 선별할 수 있었다. 본 발명의 탈모 예측용 프라이머 세트를 이용하여, 상기 12개의 SNP의 존재 여부를 판단함으로써, 탈모의 예측이 가능하며, 기존 검사에 비하여 더욱 많은 수의 SNP 마커를 검사함에 따라, 그 예측률도 매우 높은 장점이 있다. In the present invention, 12 SNPs characteristically found in the hair loss group were selected by comparing the SNPs of the hair loss group and the control group. By determining the presence of the 12 SNPs using the primer set for predicting hair loss of the present invention, it is possible to predict hair loss, and as the number of SNP markers is examined compared to the existing test, the prediction rate is also very high. There is an advantage.
한편, 본 발명은 인간 DNA의 rs6113491, rs201571, rs1998076, rs6137444, rs2180439, rs1352015, rs1160312, rs756853, rs2249817, rs7910290, rs6601957 및 rs11253156를 포함하도록 PCR 증폭하여 증폭산물을 회수하는 단계 (a); 및, 상기 증폭산물에서, rs6113491, rs201571, rs1998076, rs6137444, rs2180439, rs1352015, rs1160312, rs756853, rs2249817, rs7910290, rs6601957 및 rs11253156의 단일염기다형성을 분석하여 개별 유전자형을 결정하는 단계 (b);를 포함하는 것을 특징으로 하는 탈모 예측 방법을 제공하는데, 본 발명의 탈모 예측방법은, 상기 단계 (b) 후, 바람직하게 개별 유전자형에 따른 탈모 형질을 분석하고, 탈모 예상 정도를 판정하는 단계 (c);를 더 포함하는 것이 좋다. Meanwhile, the present invention provides a method for recovering amplification products by PCR amplifying rs6113491, rs201571, rs1998076, rs6137444, rs2180439, rs1352015, rs1160312, rs756853, rs2249817, rs7910290, rs6601957 and rs11253156 of human DNA (a); And determining the individual genotypes by analyzing single base polymorphisms of rs6113491, rs201571, rs1998076, rs6137444, rs2180439, rs1352015, rs1160312, rs756853, rs2249817, rs7910290, rs6601957 and rs11253156 in the amplification product (b); It provides a hair loss prediction method characterized in that, the hair loss prediction method of the present invention, after the step (b), preferably analyzing the hair loss trait according to the individual genotype, and (c) determining the expected degree of hair loss; It is better to include more.
본 발명에서 기재한 '개별 유전자형에 따른 탈모 형질'은 본 발명의 12개 SNP를 바탕으로 탈모 가능성을 %로 분류한 것이다. 즉, 총 12개 SNP 중 12개 모두의 탈모 관련 SNP를 보유한 유전자형은 '100% 탈모 형질'로 분류하고, 총 12개 SNP 중 1개의 탈모 관련 SNP를 보유한 유전자형은 '8% (1/12×100) 탈모 형질'로 분류한 것이다. 즉, 본 발명에서 상술하는 '개별 유전자형에 따른 탈모 형질 분석'은 본 발명에서 발굴한 12개의 탈모 예측 SNP 마커 중 개인이 보유하는 SNP의 개수에 따라, 탈모 발현 가능성을 예측하는 것이다.The 'hair loss trait according to the individual genotype' described in the present invention is classified as a percentage of hair loss based on the 12 SNPs of the present invention. That is, genotypes having all 12 hair loss-related SNPs among 12 SNPs are classified as' 100% alopecia trait ', and genotypes having one hair loss-related SNP out of 12 SNPs are' 8% (1/12 ×). 100) hair loss traits. That is, the 'hair loss trait analysis according to the individual genotypes' described in the present invention is to predict the possibility of hair loss according to the number of SNPs possessed by the individual among the 12 hair loss prediction SNP markers discovered in the present invention.
일 예로, 본 발명의 탈모 예측용 프라이머 세트를 이용하여, 개인의 SNP를 분석한 결과, 김모씨는 1개의 탈모관련 SNP를, 이모씨는 5개의 탈모관련 SNP를 보유하는 것으로 확인되었다면, 김모씨의 탈모 가능성은 약 8%로 판정이 가능할 것이며, 이모씨의 탈모 가능성은 약 42%로 판정 가능할 것이다. 이처럼 개인의 SNP 분석 결과, 개인이 보유하는 SNP(본 발명에서 발굴한 12개의 탈모 예측 SNP 마커)의 개수가 많을수록 탈모로 발전할 가능성이 매우 높은 것로 판정할 수 있는 것이다.For example, using the primer set for predicting hair loss of the present invention, as a result of analyzing an individual SNP, if it is confirmed that Kim has one hair loss-related SNP and aunt has five hair loss-related SNPs, hair loss of Kim hair The likelihood will be about 8%, and the likelihood of hair loss will be about 42%. As a result of the SNP analysis of the individual as described above, the larger the number of SNPs (12 hair loss prediction SNP markers discovered in the present invention) held by the individual, the more likely it is that the development of hair loss is very high.
이상에서와 같이 본 발명은 상기 탈모 예측 방법을 제공함에 따라, 탈모를 진단할 수 있는 표준화된 검사법을 제시하고 있는 것이다. 본 발명에 따르면 탈모와 관련한 유전자를 분석함으로써, 탈모의 조기 진단 및 조기 치료가 가능하여 경제적 부담을 줄일 수 있다. As described above, the present invention provides a standardized test method for diagnosing hair loss by providing the hair loss prediction method. According to the present invention, by analyzing the genes related to hair loss, it is possible to early diagnosis and early treatment of hair loss, thereby reducing the economic burden.
기존의 탈모진단은 단지 탈모가 진행되었을 시에만 치료를 제공하는 시스템이었지만, 본 연구개발을 통한 맞춤형 탈모 예측진단 키트는 증상이 나타나기 전에 근본 원인을 찾아 탈모 위험군, 탈모 중증도, 조기탈모 등을 선행 선별할 수 있는 예측진단으로 개인의 특성에 맞게 치료가 가능한 이점이 있다.Conventional hair loss diagnosis was a system to provide treatment only when the hair loss progressed, but the customized hair loss predictive diagnosis kit through this research and development prior to screening the root cause, hair loss severity, early hair loss, etc. Predictive diagnostics is an advantage that can be treated according to the characteristics of the individual.
이하, 본 발명의 구성을 하기 실시예를 통해 구체적으로 설명하고자 한다. 다만, 본 발명의 권리범위가 하기 실시예에만 한정되는 것은 아니고, 그와 등가의 기술적 사상의 변형까지를 포함한다.Hereinafter, the configuration of the present invention will be described in detail through the following examples. However, the scope of the present invention is not limited only to the following examples, but includes modifications of equivalent technical ideas.
[[ 제조예Production Example 1: SNP(single nucleotide polymorphism) 선정] 1: Selection of single nucleotide polymorphism (SNP)]
(1) DNA 추출(1) DNA extraction
탈모군 40명과 대조군 10명의 혈액으로부터 DNA를 추출하였다.DNA was extracted from the blood of 40 hair loss groups and 10 control groups.
(2) NGS library 제작(2) NGS library production
추출한 유전체(genomic) DNA는 음파처리(sonication)를 통하여 단편화한 후에 SureSelectXT Human All Exon Kit을 이용하여 다음과 같은 과정을 수행하였다. 말단수정(end repairing), 비드정제(bead purification), 3'-말단 아데닐화(3'-end adenylation), 어댑터 연결(adaptor ligation)의 과정을 거쳐 어뎁터-태그된 DNA 라이브러리(adaptor-tagged DNA library)를 제작하고, 이를 증폭하여 DNA 라이브러리를 준비하였다. DNA 라이브러리와 캡튜어 라이브러리(captured library)의 혼성(hybridization)를 통하여 캡튜어 라이브러리를 생성하고 인덱싱 프라이머(indexing primer)를 사용한 PCR 증폭을 통하여 인덱스된, 타겟-농축된 NGS 라이브러리(indexed, target-enriched NGS library)를 얻을 수 있었다. 도 1은 NGS 타켓 농축법의 모식도를 나타낸 것이다.The extracted genomic DNA was fragmented through sonication and then subjected to the following process using SureSelectXT Human All Exon Kit. Adapter-tagged DNA library through end repairing, bead purification, 3'-end adenylation, adapter ligation ) Was prepared and amplified to prepare a DNA library. Targeted-enriched NGS libraries (indexed, target-enriched), generated by capturing the capturing library through hybridization of the DNA library and the captured library, and PCR amplification using indexing primers. NGS library). Figure 1 shows a schematic diagram of the NGS target concentration method.
(3) PCR 증폭 및 염기서열 생성 (sequencing platforms)(3) PCR amplification and sequencing platforms
일루미사의 c-Bot 기기를 이용하여 타겟-농축된 NGS 라이브러리(target-enriched DNA library)의 클러스터 제너레이션(cluster generation)을 진행하고 일루미나사의 HiSeq2500 기기를 이용하여 클러스터(cluster)가 만들어진 유세포(flow cell)에서 염기서열분석을 수행하였다. NGS 방법으로 분석된 염기서열 결과는 생물정보학 툴(bioinformatics tool) 및 통계적 기법으로 그 결과가 정상적인지 판단하였으며, 통합 지노믹 뷰어(Intergrative Genomic Viewer)를 통해 진유전체 시퀀싱 데이터(exome sequencing data)를 얼라인먼트(alignment)하여 분석하였다. 도 2는 염기서열 생성 모식도를 나타낸 것이다.Cluster generation of target-enriched DNA library using Illumina c-Bot instrument and flow cell in which cluster was created using Illumina HiSeq2500 instrument. Sequencing was performed at. The sequencing results analyzed by the NGS method were determined by the bioinformatics tool and the statistical method, and the alignment of the exogenous sequencing data was aligned through the integrated geographic viewer. analysis was performed. Figure 2 shows a base sequence generation schematic.
(4) SNP(single nucleotide polymorphism) 마커 발굴(4) Discovery of single nucleotide polymorphism markers
대조군과 실험군의 염기서열을 분석하여 각각의 베리언트 리스트(variant list)를 작성하고, 대조군과 실험군 사이에서 차이를 보이는 SNP을 리스팅 하였다. 또한, 성별과 나이를 보정한 결과를 작성하였다. 두 리스트에 모두 리포팅된 SNP를 조사하였고, 그 중에서 유의확률(p-value)이 낮은 순으로 정렬하였다.Variant sequences of the control group and the experimental group were analyzed to prepare a variant list, and SNPs showing differences between the control group and the experimental group were listed. In addition, gender and age corrections were made. The reported SNPs were examined in both lists, and they were sorted in descending order of significance (p-value).
(5) SNP(single nucleotide polymorphism) (5) single nucleotide polymorphism (SNP) 마커Marker 선정. selection.
유의확률이 낮은 SNP을 포함하는 유전자들의 탈모 관련성을 문헌조사를 통하여 확인하였다. 이 중에서 3 좌위의 SNP(rs7910290, rs6601957, rs11253156)가 한 유전자(TUBAL3) 내에 존재하고, 또한 원형 탈모 병변에서 알파-튜불린(alpha-tubulin)의 발현량이 감소한다는 보고(Scientific Reports, (2018) 8:521) 가 있으므로 이 TUBAL3 유전자의 SNP인 rs7910290, rs6601957, rs11253156가 탈모와 높은 연관성이 있을 것으로 추정하였다. 따라서 SNP rs7910290, rs6601957, rs11253156를 검사 SNP으로 선정하였다. 또한, 탈모 예측 확률을 높이기 위하여 이미 잘 알려진 탈모 관련 SNP을 검사 대상 마커로 선정하였다. 최종적으로 탈모를 예측할 수 있는 총 12개의 SNP 마커를 선정하여 하기 표 1에 나타내었다. A literature review confirmed the alopecia of genes containing SNPs with low probability. Among these, three locus of SNPs (rs7910290, rs6601957, rs11253156) are present in one gene (TUBAL3), and the expression level of alpha-tubulin is reduced in alopecia areata (Scientific Reports, (2018) 8: 521), it is estimated that rs7910290, rs6601957, and rs11253156 of SNPs of this TUBAL3 gene are highly associated with hair loss. Therefore, SNP rs7910290, rs6601957 and rs11253156 were selected as test SNPs. In addition, in order to increase the probability of hair loss, a well-known hair loss-related SNP was selected as a test target marker. Finally, a total of 12 SNP markers capable of predicting hair loss were selected and shown in Table 1 below.
[[ 실시예Example 1: 탈모 예측용 1: for hair loss prediction 키트(multiplex SNaPshot Kit)Kit (multiplex SNaPshot Kit) 의 개발]Development of
(1) 탈모 예측용 (1) hair loss prediction 키트의Of kit 구성 Configuration
PCR 방법과 SBE(single Base Extension) 방법을 활용하여 본 발명의 탈모 예측용 키트를 구성하였다. The kit for predicting hair loss of the present invention was constructed by using a PCR method and a single base extension (SBE) method.
상기 제조예 1에서 선정한 12개의 SNP 마커 부위를 증폭하기 위한 프라이머 세트와 각 SNP 마커의 확인을 위한 SBE(single Base Extension) 프라이머 세트를 개발하여, 하기 표 2와 3에 나타내었다.A primer set for amplifying the 12 SNP marker sites selected in Preparation Example 1 and a SBE (single base extension) primer set for identifying each SNP marker were developed and shown in Tables 2 and 3 below.
rs2180439
(2) 탈모 예측용 (2) hair loss prediction 키트Kit (multiplex (multiplex SNaPshotSNaPshot Kit) 조건 개발 Kit condition development
분석에 필요한 시약은 SNPs의 증폭을 위한 세트와 SNPs의 확인을 위한 세트, 이 두 가지로 나뉜다. SNPs의 증폭을 위한 시약은 DOW Hair-Loss QuickFinder HLQF Taq, 10X HLQF Taq Buffer 및 상기에서 제작한 프라이머 세트로 구성하였고(상기 표 2), 증폭과정 후에 SNPs의 확인을 위한 시약은 DOW Hair-Loss QuickFinder SNaPshot mix (형광 표지된 ddNTPs, buffer)와 상기에서 제작한 SBE 프라이머 세트(상기 표 3)로 구성한 후, 반응조건을 하기와 같이 최적화하였다. There are two types of reagents for analysis: a set for amplification of SNPs and a set for identification of SNPs. Reagents for amplification of SNPs consisted of DOW Hair-Loss QuickFinder HLQF Taq, 10X HLQF Taq Buffer and primer set prepared above (Table 2), and the reagent for identifying SNPs after amplification was DOW Hair-Loss QuickFinder After the SNaPshot mix (fluorescent labeled ddNTPs, buffer) and the SBE primer set (Table 3) prepared above, the reaction conditions were optimized as follows.
기존의 SNP분석을 위한 시퀀싱 분석방법에서는 10ng 이상의 시료에서 염기 서열 분석이 가능하였으나, 본 발명에 따른 탈모 예측용 키트를 이용한 유전자 분석에서 1ng 이상의 시료에도 분석이 가능하도록 반응 조건을 최적화하였다. In the conventional sequencing analysis method for SNP analysis, sequencing was possible in samples of 10 ng or more, but the reaction conditions were optimized to enable analysis in samples of 1 ng or more in gene analysis using the kit for predicting hair loss according to the present invention.
SNP 마커별로 증폭되는 정도에 있어서 차이가 발생할 경우, SNP 유전자형 판독이 정확하지 않을 수 있기 때문에, 피크 높이(Peak Height)의 범위가 100 ~ 4000 RFU 증폭범위 이내에 있도록 하여 안정적인 유전자형 판독 여부를 확인할 수 있도록 최적화하였다.If there is a difference in the degree of amplification for each SNP marker, the SNP genotype reading may not be accurate, so that the peak height range is within the range of 100 to 4000 RFU amplification so that a stable genotype reading can be confirmed. Optimized.
또한, 탈모를 예측할 수 있는 12개 SNPs에 대한 SBE 프라이머 조합 조건을 확립하고 각 SNP 마커 식별이 가능하도록 개발하였다. 최적화한 반응 조건은 하기와 같다, In addition, SBE primer combination conditions for 12 SNPs predicting hair loss were established and developed to identify each SNP marker. The optimized reaction conditions are as follows.
우선, SNPs 부위의 증폭을 위한 PCR 조성은 1 ~ 60ng의 유전체(genomic) DNA, 0.4㎕의 DOW Hair-Loss QuickFinder HLQF Taq, 2㎕의 10X HLQF Taq Buffer, 5㎕의 SNP 마커 증폭용 프라이머 세트 (상기 표 2), 총 용량은 20㎕으로 설정하였다.First, PCR composition for amplification of SNPs was composed of 1 ~ 60ng of genomic DNA, 0.4µl of DOW Hair-Loss QuickFinder HLQF Taq, 2µl of 10X HLQF Taq Buffer, and 5µl of SNP marker amplification primer set. Table 2), the total dose was set to 20 μl.
상기와 같은 PCR 조성으로 하기와 같이 PCR을 수행하였다. 온도, 시간 및 사이클 (cycle)은 95℃에서 5분 (1 사이클, 즉 1회 반복), 이어서, 95℃에서 20초, 58℃에서 30초, 72℃에서 30초 조건으로 37 사이클 (즉 37회 반복), 마지막으로 72℃에서 5분간 1 사이클 (1회)의 조건으로 수행하였다.PCR was carried out with the PCR composition as described above. The temperature, time and cycle are 5 minutes at 95 ° C. (1 cycle, ie one repetition), followed by 37 cycles (ie 37 seconds at 20 ° C. at 95 ° C., 30 seconds at 58 ° C., 30 seconds at 72 ° C.). Cycles), and finally one cycle (once) at 72 ° C. for 5 minutes.
PCR 생성물에 포함된 잔여 dNTP와 프라이머는 이어지는 과정을 저해하므로 PCR 생성물, 5㎕와 ExoSAP-IT (Thermo Fisher Scientific), 1㎕을 섞고 37℃에서 45분, 그리고 80℃에서 15분 동안 반응하여 잔여 dNTP와 프라이머를 제거하였다.Residual dNTPs and primers contained in the PCR product inhibit the subsequent process, so the PCR product, 5 μl and ExoSAP-IT (Thermo Fisher Scientific), 1 μl are mixed and reacted for 45 minutes at 37 ° C. and 15 minutes at 80 ° C. dNTP and primers were removed.
SBE(Single-nucleotide extension) 과정의 수행을 위한 조성은 4㎕의 반응생성물, 5㎕의 DOW Hair-Loss QuickFinder SNaPshot mix, 1㎕의 SNP 마커 확인용 SBE 프라이머 세트 (표 3)로 설정하였다.The composition for performing the single-nucleotide extension (SBE) process was set to 4 μl of reaction product, 5 μl of DOW Hair-Loss QuickFinder SNaPshot mix, and 1 μl of SBE primer set (Table 3).
SBE 과정은 95℃에서 10초, 50℃에서 10초, 60℃에서 30초의 조건으로 25 사이클 (즉 25회 반복)으로 수행하였다.The SBE procedure was carried out in 25 cycles (ie 25 repetitions) under conditions of 10 seconds at 95 ° C, 10 seconds at 50 ° C, and 30 seconds at 60 ° C.
이후, 이어지는 과정을 저해하는 ddNTP를 제거하기 위해서, SBE 생성물에 1㎕의 SAP (Thermo Fisher Scientific), 1.2㎕의 10X SAP Buffer (Thermo Fisher Scientific)를 첨가하여 37℃에서 60분 동안 반응시킨 뒤, 65℃에서 15분 동안 반응시켰다.Then, to remove ddNTP that inhibits the subsequent process, 1 μl of SAP (Thermo Fisher Scientific), 1.2 μl of 10X SAP Buffer (Thermo Fisher Scientific) was added to the SBE product and reacted at 37 ° C. for 60 minutes. The reaction was carried out at 65 ° C. for 15 minutes.
(3) 유전자형 판독의 정확성 확인(3) Confirm the accuracy of genotype readings
상기 실시예 1로부터 얻어진 각각의 SBE 증폭 산물의 정제 후, 형광이 표지된 SBE 증폭산물을 유전적 분석기(genetic analyzer)를 이용하여, 모세관 전기영동을 실시하였다. GeneMapper 소프트웨어를 통해 SNP 유전형(genotyping) 분석을 수행하였다 (도 3, 도 4). 도 3은 유전자형 판독의 정확성을 확인하기 위한 방법(SNaPshot assay)의 모식도이고, 도 4는 SNPs에 대한 12개의 SBE 프라이머를 조합하여 동시에 증폭될 수 있도록 멀티플렉스 SNP 익스텐션 어세이(multiplex SNP extension assay)를 수행하여 유전분석을 통해 탈모예측을 검증한 결과이다.After purification of each SBE amplification product obtained in Example 1, capillary electrophoresis was performed on the fluorescently labeled SBE amplification products using a genetic analyzer. SNP genotyping analysis was performed via GeneMapper software (FIG. 3, FIG. 4). Figure 3 is a schematic diagram of a method (SNaPshot assay) to confirm the accuracy of genotype reading, Figure 4 is a multiplex SNP extension assay (multiplex SNP extension assay) to be amplified simultaneously by combining the 12 SBE primers for SNPs This is a result of verifying hair loss prediction through genetic analysis.
분석 결과, 본 발명에서 개발한 프라이머 세트는 12개의 SNPs를 동시에 효과적으로 증폭할 수 있음을 확인할 수 있었다. As a result, the primer set developed in the present invention was able to effectively amplify 12 SNPs at the same time.
본 발명을 요약하자면, 탈모를 예측하기 위하여, 탈모군과 대조군의 시료로부터 DNA를 추출하고, 탈모의 예측이 가능한 프라이머를 이용하여 PCR을 수행하였다. 이후, 상기 PCR 산물로 12개의 SBE 프라이머를 조합하여 동시에 증폭될 수 있도록 멀티플렉스 SNP 익스텐션 어세이(multiplex SNP extension assay)를 수행하며, SNP 유전체 산물로 유전분석을 수행하고, 분석 후 탈모 여부를 예측하게 되는 것이다.To summarize the present invention, in order to predict hair loss, DNA was extracted from samples of the hair loss group and the control group, and PCR was performed using primers capable of predicting hair loss. Subsequently, a multiplex SNP extension assay is performed to combine 12 SBE primers with the PCR product to be amplified at the same time, perform genetic analysis with SNP genome products, and predict hair loss after analysis. Will be done.
<110> Dowgene
<120> Kits for detecting hair loss disorders with Single Nucleotide
Polymorphism and method for detecting hair loss disorders thereby
<130> YP-18-195
<160> 36
<170> KoPatentIn 3.0
<210> 1
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> This is forward primer for amplification of rs2180439. The name
of this primer is B1_rs2180439_F1u.
<400> 1
ggttggatgg atgctggatg 20
<210> 2
<211> 22
<212> DNA
<213> Artificial Sequence
<220>
<223> This is reverse primer for amplification of rs2180439. The name
of this primer is B1_rs2180439_R2u.
<400> 2
ctgtaatggt gggcacaagt ca 22
<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> This is forward primer for amplification of rs1998076. The name
of this primer is B2_rs1998076_F2.
<400> 3
ggactgaaaa acccaccagg 20
<210> 4
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> This is reverse primer for amplification of rs1998076. The name
of this primer is B2_rs1998076_R1.
<400> 4
cggttgccca aatcaagcta 20
<210> 5
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> This is forward primer for amplification of rs6137444. The name
of this primer is B3_rs6137444_F2m.
<400> 5
gacttttggc tccaccccag 20
<210> 6
<211> 21
<212> DNA
<213> Artificial Sequence
<220>
<223> This is reverse primer for amplification of rs6137444. The name
of this primer is B3_rs6137444_R3.
<400> 6
cactccaggg acaacaacag g 21
<210> 7
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> This is forward primer for amplification of rs6113491. The name
of this primer is B4_rs6113491_F3u.
<400> 7
gcttcccttt ggacactctt 20
<210> 8
<211> 26
<212> DNA
<213> Artificial Sequence
<220>
<223> This is reverse primer for amplification of rs6113491. The name
of this primer is B4_rs6113491_R4u.
<400> 8
gtgaagtggt cagaataggt aaatcc 26
<210> 9
<211> 21
<212> DNA
<213> Artificial Sequence
<220>
<223> This is forward primer for amplification of rs201571. The name of
this primer is B5_rs201571_F5m.
<400> 9
agtccgagcc actatccttt g 21
<210> 10
<211> 22
<212> DNA
<213> Artificial Sequence
<220>
<223> This is reverse primer for amplification of rs201571. The name of
this primer is B5_rs201571_R9.
<400> 10
ggcagtcaga gaaaccatgt aa 22
<210> 11
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> This is forward primer for amplification of rs1160312. The name
of this primer is B6_rs1160312_F1m.
<400> 11
aggtagccag gaggtagaac 20
<210> 12
<211> 22
<212> DNA
<213> Artificial Sequence
<220>
<223> This is reverse primer for amplification of rs1160312. The name
of this primer is B6_rs1160312_R1u.
<400> 12
ctgtgtggca ggttaattga ga 22
<210> 13
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> This is forward primer for amplification of rs1352015. The name
of this primer is B7_rs1352015_F3.
<400> 13
attcctatcc ccgtttccag 20
<210> 14
<211> 21
<212> DNA
<213> Artificial Sequence
<220>
<223> This is reverse primer for amplification of rs1352015. The name
of this primer is B7_rs1352015_R1.
<400> 14
gccaggcact attgtaagca c 21
<210> 15
<211> 22
<212> DNA
<213> Artificial Sequence
<220>
<223> This is forward primer for amplification of rs756853. The name of
this primer is B8_rs756853_F3.
<400> 15
acgatctgaa tgtggagtgt gc 22
<210> 16
<211> 19
<212> DNA
<213> Artificial Sequence
<220>
<223> This is reverse primer for amplification of rs756853. The name of
this primer is B8_rs756853_R9.
<400> 16
tcctccccta cgctttcat 19
<210> 17
<211> 22
<212> DNA
<213> Artificial Sequence
<220>
<223> This is forward primer for amplification of rs2249817. The name
of this primer is B9_rs2249817_F9m.
<400> 17
gcatcatagg ttcacgctaa gg 22
<210> 18
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> This is reverse primer for amplification of rs2249817. The name
of this primer is B9_rs2249817_R2.
<400> 18
aggggcaatt tctatgcagc 20
<210> 19
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> This is forward primer for amplification of rs7910290. The name
of this primer is Bw8_rs7910290_F2.
<400> 19
tgaaggtaca gtccgtgtgc 20
<210> 20
<211> 21
<212> DNA
<213> Artificial Sequence
<220>
<223> This is reverse primer for amplification of rs7910290. The name
of this primer is Bw8_rs7910290_R5.
<400> 20
ggcactggtt cagggtttac g 21
<210> 21
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> This is forward primer for amplification of rs6601957. The name
of this primer is Bw9_rs6601957_F1.
<400> 21
tccctgaagt ccaccacact 20
<210> 22
<211> 23
<212> DNA
<213> Artificial Sequence
<220>
<223> This is reverse primer for amplification of rs6601957. The name
of this primer is Bw9_rs6601957_R1u.
<400> 22
gctctgaagt gctttgccta ctc 23
<210> 23
<211> 19
<212> DNA
<213> Artificial Sequence
<220>
<223> This is forward primer for amplification of rs11253156. The name
of this primer is Bw10_rs11253156_F1u.
<400> 23
cagggagaga cggttggtg 19
<210> 24
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> This is reverse primer for amplification of rs11253156. The name
of this primer is Bw10_rs11253156_R4u.
<400> 24
cagcaccgtt cactcttcca 20
<210> 25
<211> 22
<212> DNA
<213> Artificial Sequence
<220>
<223> This is SBE primer for confirmation of rs6113491.
<400> 25
ttgggagaaa tagggagcaa tt 22
<210> 26
<211> 29
<212> DNA
<213> Artificial Sequence
<220>
<223> This is SBE primer for confirmation of rs201571.
<400> 26
ttggaaccag aaaaacaatg tctatttag 29
<210> 27
<211> 35
<212> DNA
<213> Artificial Sequence
<220>
<223> This is SBE primer for confirmation of rs1998076.
<400> 27
ttttttttaa ttctcatctg agttaacaga tttgg 35
<210> 28
<211> 40
<212> DNA
<213> Artificial Sequence
<220>
<223> This is SBE primer for confirmation of rs6137444.
<400> 28
tttttttttt ttttttggat tagactgcta actttttaaa 40
<210> 29
<211> 45
<212> DNA
<213> Artificial Sequence
<220>
<223> This is SBE primer for confirmation of rs2180439.
<400> 29
tttttttttt tttttttttt taatctagct gccgttttgt gttat 45
<210> 30
<211> 52
<212> DNA
<213> Artificial Sequence
<220>
<223> This is SBE primer for confirmation of rs1352015.
<400> 30
tttttttttt tttttttttt tttttttttt ttatgctatg aggccatggt ac 52
<210> 31
<211> 58
<212> DNA
<213> Artificial Sequence
<220>
<223> This is SBE primer for confirmation of rs1160312.
<400> 31
tttttttttt tttttttttt tttttttttt tttttttttt agtgtggggt caggactc 58
<210> 32
<211> 63
<212> DNA
<213> Artificial Sequence
<220>
<223> This is SBE primer for confirmation of rs756853.
<400> 32
tttttttttt tttttttttt tttttttttt tttttttttt accttgtact tcttgttcga 60
gga 63
<210> 33
<211> 68
<212> DNA
<213> Artificial Sequence
<220>
<223> This is SBE primer for confirmation of rs2249817.
<400> 33
tttttttttt tttttttttt tttttttttt tttttttttt tttcctctgt tcattatagt 60
gaccaaaa 68
<210> 34
<211> 73
<212> DNA
<213> Artificial Sequence
<220>
<223> This is SBE primer for confirmation of rs7910290.
<400> 34
tttttttttt tttttttttt tttttttttt tttttttttt ttttttttag acagagttat 60
aaggctctac cac 73
<210> 35
<211> 78
<212> DNA
<213> Artificial Sequence
<220>
<223> This is SBE primer for confirmation of rs6601957.
<400> 35
tttttttttt tttttttttt tttttttttt tttttttttt tttttttttt tttttttacc 60
agaagcagtg aattggac 78
<210> 36
<211> 83
<212> DNA
<213> Artificial Sequence
<220>
<223> This is SBE primer for confirmation of rs11253156.
<400> 36
tttttttttt tttttttttt tttttttttt tttttttttt tttttttttt tttttttttt 60
tttcggcctc gtgcgtaatt gtt 83
<110> Dowgene
<120> Kits for detecting hair loss disorders with Single Nucleotide
Polymorphism and method for detecting hair loss disorders thereby
<130> YP-18-195
<160> 36
<170> KoPatentIn 3.0
<210> 1
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> This is forward primer for amplification of rs2180439. The name
of this primer is B1_rs2180439_F1u.
<400> 1
ggttggatgg atgctggatg 20
<210> 2
<211> 22
<212> DNA
<213> Artificial Sequence
<220>
<223> This is reverse primer for amplification of rs2180439. The name
of this primer is B1_rs2180439_R2u.
<400> 2
Claims (5)
A primer set for detecting alopecia predicting SNP markers, comprising primers represented by nucleic acid sequences of SEQ ID NOs: 1 to 24.
상기 탈모 예측 SNP 마커 검출용 프라이머 세트는,
서열번호 25 내지 36의 핵산서열로 표시되는 각각의 프라이머들을 더 포함하는 것을 특징으로 하는 탈모 예측 SNP 마커 검출용 프라이머 세트.
The method of claim 1,
The primer set for detecting the hair loss prediction SNP marker,
A primer set for detecting hair loss predicting SNP markers, further comprising respective primers represented by nucleic acid sequences of SEQ ID NOs: 25 to 36.
Diagnosis for predicting hair loss comprising a primer set for detecting SNP markers comprising respective primers represented by the nucleic acid sequence of SEQ ID NO: 1 to 24 and each primer represented by the nucleic acid sequence of SEQ ID NO: 25 to 36 Kit.
상기 증폭산물에서, rs6113491, rs201571, rs1998076, rs6137444, rs2180439, rs1352015, rs1160312, rs756853, rs2249817, rs7910290, rs6601957 및 rs11253156의 단일염기다형성을 분석하여 개별 유전자형을 결정하는 단계 (b);를 포함하는 것을 특징으로 하는 탈모 예측 방법.
Recovering the amplification product by PCR amplification to include rs6113491, rs201571, rs1998076, rs6137444, rs2180439, rs1352015, rs1160312, rs756853, rs2249817, rs7910290, rs6601957 and rs11253156 of human DNA (a); And,
(B) analyzing single base polymorphisms of rs6113491, rs201571, rs1998076, rs6137444, rs2180439, rs1352015, rs1160312, rs756853, rs2249817, rs7910290, rs6601957, and rs11253156 in the amplification product (b); Hair loss prediction method.
상기 단계 (b) 후,
개별 유전자형에 따른 탈모 형질을 분석하고, 탈모 예상 정도를 판정하는 단계 (c);를 더 포함하는 것을 특징으로 하는 탈모 예측 방법.
The method of claim 4, wherein
After step (b),
(C) analyzing the hair loss trait according to the individual genotype and determining the expected degree of hair loss.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180145519A KR102061317B1 (en) | 2018-11-22 | 2018-11-22 | Kits for detecting hair loss disorders with Single Nucleotide Polymorphism and method for detecting hair loss disorders thereby |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180145519A KR102061317B1 (en) | 2018-11-22 | 2018-11-22 | Kits for detecting hair loss disorders with Single Nucleotide Polymorphism and method for detecting hair loss disorders thereby |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102061317B1 true KR102061317B1 (en) | 2020-01-02 |
Family
ID=69155205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180145519A KR102061317B1 (en) | 2018-11-22 | 2018-11-22 | Kits for detecting hair loss disorders with Single Nucleotide Polymorphism and method for detecting hair loss disorders thereby |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102061317B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112501274A (en) * | 2020-07-14 | 2021-03-16 | 郑州金域临床检验中心有限公司 | Kit for detecting alopecia gene locus rs2180439 |
KR20220034957A (en) * | 2020-09-11 | 2022-03-21 | 서울대학교산학협력단 | Genetic polymorphic markers associated with female pattern hair loss and uses thereof |
KR20220034956A (en) * | 2020-09-11 | 2022-03-21 | 서울대학교산학협력단 | A risk prediction model of female pattern hair loss based on a set of genetic polymorphic markers |
CN117821584A (en) * | 2024-03-06 | 2024-04-05 | 首都医科大学附属北京积水潭医院 | Androgen alopecia risk gene variation detection kit and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2108704A1 (en) | 2008-04-07 | 2009-10-14 | Life & Brain GmbH | Androgenetic alopecia |
US20100028869A1 (en) | 2008-07-31 | 2010-02-04 | Shardna S.P.A. | Method to assess susceptibility to androgenic alopecia |
KR101351335B1 (en) | 2011-11-15 | 2014-01-14 | 한국과학기술연구원 | Identification Method of Metabolites and Enzymes for Prediction and Drug Evaluation in Female-Pattern Baldness |
-
2018
- 2018-11-22 KR KR1020180145519A patent/KR102061317B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2108704A1 (en) | 2008-04-07 | 2009-10-14 | Life & Brain GmbH | Androgenetic alopecia |
US20100028869A1 (en) | 2008-07-31 | 2010-02-04 | Shardna S.P.A. | Method to assess susceptibility to androgenic alopecia |
KR101351335B1 (en) | 2011-11-15 | 2014-01-14 | 한국과학기술연구원 | Identification Method of Metabolites and Enzymes for Prediction and Drug Evaluation in Female-Pattern Baldness |
Non-Patent Citations (1)
Title |
---|
PLoS ONE (2013) 8(8):e71771 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112501274A (en) * | 2020-07-14 | 2021-03-16 | 郑州金域临床检验中心有限公司 | Kit for detecting alopecia gene locus rs2180439 |
KR20220034957A (en) * | 2020-09-11 | 2022-03-21 | 서울대학교산학협력단 | Genetic polymorphic markers associated with female pattern hair loss and uses thereof |
KR20220034956A (en) * | 2020-09-11 | 2022-03-21 | 서울대학교산학협력단 | A risk prediction model of female pattern hair loss based on a set of genetic polymorphic markers |
KR102464776B1 (en) | 2020-09-11 | 2022-11-09 | 서울대학교산학협력단 | Genetic polymorphic markers associated with female pattern hair loss and uses thereof |
KR102559726B1 (en) | 2020-09-11 | 2023-07-27 | 서울대학교산학협력단 | A risk prediction model of female pattern hair loss based on a set of genetic polymorphic markers |
CN117821584A (en) * | 2024-03-06 | 2024-04-05 | 首都医科大学附属北京积水潭医院 | Androgen alopecia risk gene variation detection kit and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200385810A1 (en) | Methods for determining fraction of fetal nucleic acids in maternal samples | |
KR102061317B1 (en) | Kits for detecting hair loss disorders with Single Nucleotide Polymorphism and method for detecting hair loss disorders thereby | |
EP3382037B1 (en) | Methods for determining fraction of fetal nucleic acids in maternal samples | |
EP2358907B1 (en) | Autism associated genetic markers | |
US11542556B2 (en) | Single nucleotide polymorphism in HLA-B*15:02 and use thereof | |
KR101667526B1 (en) | Method for Extended Autosomal STR Analysing Human Subject of Analytes using a Next Generation Sequencing Technology | |
WO2013103945A1 (en) | Composite assay for developmental disorders | |
WO2017112738A1 (en) | Methods for measuring microsatellite instability | |
CN111286548A (en) | Kit for detecting 68 loci based on next-generation sequencing technology and primer combination used by kit | |
JP2022002539A (en) | Major histocompatibility complex single nucleotide polymorphisms | |
US20100099082A1 (en) | Allele Detection | |
KR20180043068A (en) | Noninvasive prenatal diagnosis method for autosomal recessive disease using picodrolet digital PCR and kit therefor | |
Zhu et al. | Genetic analysis of STR markers on chromosome 21 in a Han population from southeast China | |
RU2777078C1 (en) | Method for pre-implantation genetic testing of cystic fibrosis | |
KR102167792B1 (en) | Composition for early predicting or diagnosing hypercalcemia in dog | |
KR102511596B1 (en) | A single nucleotide polymorphism marker composition for diagnosing an adverse reactions with angiotensin converting enzyme inhibitor and a method using the same | |
RU2769300C1 (en) | Test system for pre-implantation genetic testing of type 1 spinocerebellar ataxia | |
RU2772938C1 (en) | Method for pre-implantation genetic testing of familial hypertrophic cardiomyopathy | |
RU2777091C1 (en) | Method for pre-implantation genetic testing of breast and ovarian cancer | |
RU2777081C1 (en) | Method for pre-implantation genetic testing of louis-bar syndrome | |
Gang et al. | Single-Nucleotide Polymorphism: A Forensic Perspective | |
KR20160083758A (en) | Detection of mutations in ATP7B gene using PCR-LDR | |
KR101075392B1 (en) | Polynucleotides comprising single nucleotide polymorphism derived from FGA gene, microarrays and diagnostic kits comprising the same, and detection methods using the same | |
JP2005110607A (en) | Method for examining predisposing factor of hypertensive cardiomegaly |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |